Play Video This will play a video - Video thumbnail

Diagnosing Syncope Is Challenging. Getting Answers is Urgent.

Hear What Patients Say
Alert Indications, Safety, and Warnings

Half of Patients

Admitted to the Hospital for Syncope

Leave without a Diagnosis.¹

Illustration of three people in teal, three in navy blue to indicate patients split in half

An Average of 251,000 People Are Hospitalized for Syncope Every Year.²

ACC/AHA/HRS & ESC Syncope Guidelines

Recommend insertable cardiac monitoring (ICM) in the evaluation of unexplained syncope.3,4

View Guideline Highlights

Cardiac Syncope Is Deadly.

Cardiac syncope can be a predictor of sudden cardiac death.5

Blue box with the number 2 and letter x inside

2X increased risk of death.⁶

Navy box with number 10 and % symbol inside

> 10% mortality rate at six months.⁶

Syncope Patients Need Answers.

They live with anxiety, fear, and depression.

Learn about Reveal LINQ ICM System
Reveal LINQ insertable cardiac monitor on navy blue gradient background

 

Reveal LINQ™ ICM cardiac monitoring up to three years⁷

Play Video This will play a video - Video thumbnail

Reveal LINQ ICM helped William's physician find answers for his unexplained syncope.

3.6X

More Likely to Reach a Diagnosis with ICM versus Standard of Care⁴

ACC/AHA/HRS 2017 Guidelines

See Guideline Highlights

ESC 2018 Guidelines

View Guideline Highlights Here

Choose the Right Monitor

For the Right Patient.

Choose a diagnostic monitor based on frequency of symptoms.

Blue and gray chart showing three diagnostic monitors to select based on frequency of symptoms

Continue Monitoring. Get to the Answer.

If initial monitoring is nondiagnostic, keep looking with Reveal LINQ ICM.

Middle-aged male physician wearing a white coat

20% of Syncope Diagnosed with Reveal™ ICM Occurred after two years10

Select Reveal LINQ for up to three years of cardiac monitoring.

References

1

Mendu ML, McAvay G, Lampert R, Stoehr J, Tinetti ME. Yield of diagnostic tests in evaluating syncopal episodes in older patients. Arch Intern Med. July 27, 2009;169(14):1299-1305.

2

Data obtained from CDC National Hospital Ambulatory Medical Care Survey (NHAMCS) from the years 2008-2014.

3

Shen WK, Sheldon RS, Benditt DG, et al. 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society. J Am Coll Cardiol. August 1, 2017;70(5):e39-e110.

4

Brignole M, Moya A, de Lange F, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. June 1, 2018;39(21):1883-1948.

5

Brugada R, et al., eds. Clinical Approach to Sudden Cardiac Death Syndromes. London: Springer-Verlag; 2010.

6

Soteriades ES, Evans JC, Larson MG, et al. Incidence and prognosis of syncope. N Engl J Med. September 19, 2002;347(12):878-885.

7

Reference the Reveal LINQ ICM Clinician Manual for usage parameters.

8

Brignole M, Auricchio A, Baron-Esquivias G, et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. August 2013;34(29):2281-2329.

9

NICE Clinical Syncope Guideline CG109, 2010. Available at https://www.nice.org.uk/guidance/cg109. Accessed April 9, 2021.

10

Furukawa T, Maggi R, Bertolone C, Fontana D, Brignole M. Additional diagnostic value of very prolonged observation by implantable loop recorder in patients with unexplained syncope. J Cardiovasc Electrophysiol. January 2012;23(1):67-71.